Immuneering (IMRX) had the highest return on September 16, 2024 by a small-cap US stock, returning 41.4%.

ASSET	DATE	% RETURN
Immuneering (IMRX)	9/16/2024	41.38%
Microvast (MVST)	9/16/2024	20.87%
Alliance Entertainment Holding Corporation Class A Common Stock (AENT)	9/16/2024	20%
Greenfire Resources (GFR)	9/16/2024	15.31%
Bicara Therapeutics Inc Common Stock (BCAX)	9/16/2024	13.74%
Qilian International (BGM)	9/16/2024	12.76%
Montana Technologies (AIRJ)	9/16/2024	12.29%
Microvision (MVIS)	9/16/2024	11.34%
Sable Offshore (SOC)	9/16/2024	10.84%
Gevo (GEVO)	9/16/2024	10.4%
Corvus Pharmaceuticals (CRVS)	9/16/2024	10.1%
Maravai Lifesciences Holdings (MRVI)	9/16/2024	9.07%
Veritone (VERI)	9/16/2024	8.9%
Alpha Technology Group Limited Ordinary Shares (ATGL)	9/16/2024	8.66%
Opko Health (OPK)	9/16/2024	7.89%
Crawford (CRD.B)	9/16/2024	7.72%
Loandepot (LDI)	9/16/2024	7.41%
Pulse Biosciences (PLSE)	9/16/2024	7.32%
Monopar Therapeutics (MNPR)	9/16/2024	7.16%
Nathans Famous (NATH)	9/16/2024	7.01%
Vera Therapeutics (VERA)	9/16/2024	6.59%
Cellectis (CLLS)	9/16/2024	6.48%
Mobilicom Limited Warrants (MOBBW)	9/16/2024	6.43%
Seaport Entertainment (SEG)	9/16/2024	6.39%
Anavex Life Sciences (AVXL)	9/16/2024	6.34%

Small-cap stocks are treated as having a market cap between $300M and $2B.